Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1952 1
1959 2
1960 1
1961 1
1962 4
1963 5
1964 7
1965 9
1966 10
1967 9
1968 9
1969 16
1970 20
1971 13
1972 11
1973 7
1974 25
1975 9
1976 20
1977 35
1978 27
1979 37
1980 42
1981 51
1982 44
1983 39
1984 52
1985 27
1986 32
1987 39
1988 39
1989 64
1990 49
1991 55
1992 43
1993 43
1994 50
1995 55
1996 70
1997 72
1998 69
1999 53
2000 65
2001 84
2002 88
2003 69
2004 70
2005 86
2006 106
2007 97
2008 102
2009 107
2010 96
2011 106
2012 123
2013 117
2014 131
2015 138
2016 175
2017 184
2018 162
2019 194
2020 210
2021 220
2022 20
Text availability
Article attribute
Article type
Publication date

Search Results

3,740 results
Results by year
Filters applied: . Clear all
Page 1
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, Mendez G, Feliciano J, Motoyama S, Lièvre A, Uronis H, Elimova E, Grootscholten C, Geboes K, Zafar S, Snow S, Ko AH, Feeney K, Schenker M, Kocon P, Zhang J, Zhu L, Lei M, Singh P, Kondo K, Cleary JM, Moehler M; CheckMate 577 Investigators. Kelly RJ, et al. Among authors: kondo k. N Engl J Med. 2021 Apr 1;384(13):1191-1203. doi: 10.1056/NEJMoa2032125. N Engl J Med. 2021. PMID: 33789008 Clinical Trial.
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, Wyrwicz L, Yamaguchi K, Skoczylas T, Campos Bragagnoli A, Liu T, Schenker M, Yanez P, Tehfe M, Kowalyszyn R, Karamouzis MV, Bruges R, Zander T, Pazo-Cid R, Hitre E, Feeney K, Cleary JM, Poulart V, Cullen D, Lei M, Xiao H, Kondo K, Li M, Ajani JA. Janjigian YY, et al. Among authors: kondo k. Lancet. 2021 Jul 3;398(10294):27-40. doi: 10.1016/S0140-6736(21)00797-2. Epub 2021 Jun 5. Lancet. 2021. PMID: 34102137 Free PMC article. Clinical Trial.
A first case of meningitis/encephalitis associated with SARS-Coronavirus-2.
Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M, Sakata H, Kondo K, Myose N, Nakao A, Takeda M, Haro H, Inoue O, Suzuki-Inoue K, Kubokawa K, Ogihara S, Sasaki T, Kinouchi H, Kojin H, Ito M, Onishi H, Shimizu T, Sasaki Y, Enomoto N, Ishihara H, Furuya S, Yamamoto T, Shimada S. Moriguchi T, et al. Among authors: kondo k. Int J Infect Dis. 2020 May;94:55-58. doi: 10.1016/j.ijid.2020.03.062. Epub 2020 Apr 3. Int J Infect Dis. 2020. PMID: 32251791 Free PMC article.
Efficacy of Biofeedback for Medical Conditions: an Evidence Map.
Kondo K, Noonan KM, Freeman M, Ayers C, Morasco BJ, Kansagara D. Kondo K, et al. J Gen Intern Med. 2019 Dec;34(12):2883-2893. doi: 10.1007/s11606-019-05215-z. Epub 2019 Aug 14. J Gen Intern Med. 2019. PMID: 31414354 Free PMC article. Review.
Retraction: Activation of epidermal growth factor receptor/p38/hypoxia-inducible factor-1 α is pivotal for angiogenesis and tumorigenesis of malignantly transformed cells induced by hexavalent chromium.
Kim D, Dai J, Park YH, Fai LY, Wang L, Pratheeshkumar P, Son YO, Kondo K, Xu M, Luo J, Shi X, Zhang Z. Kim D, et al. Among authors: kondo k. J Biol Chem. 2019 Oct 18;294(42):15558. doi: 10.1074/jbc.RX119.011168. J Biol Chem. 2019. PMID: 31628199 Free PMC article. No abstract available.
3,740 results